BNR

Burning Rock Biotech Limited

0.80 USD
+0.02 (+2.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Burning Rock Biotech Limited stock is down -20% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 December’s closed higher than November.

About Burning Rock Biotech Limited

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. Its products include OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass IO, the corresponding test for liquid biopsy samples. The company also offers LungCore for lung cancer, ProstrateCore for prostrate cancer, BreastCore for breast cancer, LymphPlasma for lymphomas, and ThyroCare for thyroid cancer.